RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells

por Patel, Hima, Mishra, Rosalin, Wier, Adam, Mokhtarpour, Nazanin, Merino, Edward J., Garrett, Joan T.
Publicado 2023